Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
McKesson
Mallinckrodt
Medtronic
Dow

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Allergan Herbert Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for ALLERGAN HERBERT, and what generic and branded alternatives to ALLERGAN HERBERT drugs are available?

ALLERGAN HERBERT has twelve approved drugs.



Summary for Allergan Herbert
US Patents:0
Tradenames:6
Ingredients:5
NDAs:12

Drugs and US Patents for Allergan Herbert

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Herbert EXSEL selenium sulfide LOTION/SHAMPOO;TOPICAL 083892-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Allergan Herbert PENECORT hydrocortisone OINTMENT;TOPICAL 088217-001 Jun 6, 1984 DISCN No No   Start Trial   Start Trial
Allergan Herbert FLUONID fluocinolone acetonide GEL;TOPICAL 087300-001 May 27, 1982 DISCN No No   Start Trial   Start Trial
Allergan Herbert AEROSEB-HC hydrocortisone AEROSOL;TOPICAL 085805-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Allergan Herbert FLUONID fluocinolone acetonide CREAM;TOPICAL 087156-002 Sep 6, 1984 DISCN No No   Start Trial   Start Trial
Allergan Herbert TEMARIL trimeprazine tartrate TABLET;ORAL 011316-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Baxter
Moodys
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.